Once again, AUA’s AQUA Registry has been approved by CMS as a Qualified Clinical Data Registry (QCDR).  For the 2025 reporting year, the 54 quality measures supported by AQUA include 7 urology-specific non-QPP measures that are available only via AQUA, as well as 31 QPP measures and 16 eCQMs. The CMS-approved non-QPP measures address conditions such as prostate cancer, stones, and bladder cancer.  In addition, for 2025, AQUA will support three MVPs: Advancing Cancer Care; Focusing on Women's Health; and the new Urology MVP entitled Optimal Care for Patients with Urologic Conditions.  Finally, for the first time, AQUA will support the APM Entity participation option, meaning that those participating in a MIPS APM can now report via AQUA.  The QCDR designation is critical to the success of the AQUA Registry’s efforts to support its participants in fulfilling the MIPS reporting requirements set forth by CMS.